Arvinas Inc Conference Call Transcript
Good morning, ladies and gentlemen, and welcome to the Arvinas conference call. (Operator Instructions). I would now like to turn the call over to Randy Teel, vice president of corporate development at Arvinas. Please proceed.
Thank you very much. Good morning, everyone, and thank you for joining us today to review initial clinical data from our PROTAC protein degrader platform which will be presented today at the 2nd Targeted Protein Degradation Summit in Boston. You can access the relevant press release, 8-K filing and the slides that will be presented at 11:30 AM today in the Investors section of our website at Arvinas.com.
With me today are President and Chief Executive Officer, John Houston; Chief Medical Officer, Ron Peck; Chief Scientific Officer, Ian Taylor; and Chief Financial Officer, Sean Cassidy.
Before we begin the call I would like to remind you that today's discussion will contain forward-looking statements that involve risks and uncertainties. These risks and uncertainties
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |